America's Best Nonprofits
  1. Home
  2. Medical Research
  3. Philadelphia, PA
  4. Kidney Cancer Coalition

Kidney Cancer Coalition

Kidney Cancer Coalition is ranked #4 of 17 medical research organizations in Philadelphia, PA, with an America's Best Score of 77 out of 100, based on its 2025 Form 990.

  • Philadelphia, PA
  • Tax-exempt since 2016
  • EIN: 81-3352468
kidneycan.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
77OF 100 #4 of 17 in Philadelphia ranked medical research organizations How this score is calculated

Organization summary

Kidney Cancer Coalition is a 501(c)(3) organization, classified under Medical Research (NTEE H12). Contributions are tax-deductible.

8327 Germantown Avenue, Philadelphia, PA 19118-3455

Among the 21 scored medical research organizations in Philadelphia, Kidney Cancer Coalition holds 16.7 months of operating reserves (peer median 13.5 months), runs a typical yearly surplus of 14.0% (peers: surplus of 6.2%), and has grown spending 27.6% a year (peers: grown spending 7.3% a year).

In fiscal year 2025 it reported $1,258,754 in revenue and $1,336,045 in expenses, with contributions making up 12.7% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

Our mission is to accelerate cures for kidney cancer by: Advocating for government and industry funding, facilitating colloboration across research and clinical disciplines, and offering direct financial support for researchers with promising ideas.

Largest programs · fiscal year 2025

  • Translational kidney cancer research summit - organized and facilitated a 2 day summit bringing together thought leaders from throughout the world to discuss topics of basic translational science to advance kideny cancer research. $759,342 spent · 89.8% of program spending
  • Patient advocacy meetings - planned and organized multiple federal advocacy events to educate kidney cancer patient advocates, caregivers, researchers, clinicians and stakeholders. $86,377 spent · 10.2% of program spending
  • Patient resource center
  • facebook live event

Where each dollar went · fiscal year 2025

Of every dollar it spent, 63¢ went to programs, 37¢ to management and 0¢ to fundraising.

  • Programs $845,719
  • Management $490,326
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score77 / 100
Rank in Philadelphia#4 of 17
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves16.7 mo; 15.5 mo in cash11.6 / 25
Financial balance (median margin)+14.0%16.4 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth+27.6% / yr15 / 15
Track record10 years4 / 10
Debt load4.8% of assets10 / 10
Total77 → 77
Spending on programs
Not scored; America's Best needs 65%+
63%Below

Compared with Philadelphia peers

MeasureThis organizationPeer median
Operating reserves16.7 mo13.5 mo
Typical margin+14.0%+6.2%
Spending growth+27.6% / yr+7.3% / yr
Debt load4.8%21.7%

Peers: the 21 Philadelphia medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$1,258,754Fiscal year 20252022: $790,76420222023: $1,142,92920232024: $1,662,44620242025: $1,258,7542025
Expenses$1,336,045Fiscal year 20252022: $643,36820222023: $1,088,12920232024: $1,123,55720242025: $1,336,0452025
Total assets$1,954,314Fiscal year 20252022: $1,469,91620222023: $1,517,88120232024: $2,005,62420242025: $1,954,3142025
Total liabilities$93,315Fiscal year 20252022: $125,31520222023: $118,48020232024: $67,33420242025: $93,3152025
Fiscal year ending December 2025
Revenue$1,258,754
Expenses$1,336,045
Net income−$77,291
Net assets$1,860,999

Notable sources of revenue

Percent of total revenue
Contributions$159,236
Program services$1,022,260
Investment income$63,233
Other (net)$14,025

Assets / debt

Total assets$1,954,314
Total liabilities$93,315
Net assets$1,860,999

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$1,662,446
Expenses$1,123,557
Net income$538,889
Net assets$1,938,290

Notable sources of revenue

Percent of total revenue
Contributions$133,067
Program services$924,376
Investment income$64,937
Other (net)$540,066

Assets / debt

Total assets$2,005,624
Total liabilities$67,334
Net assets$1,938,290

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$1,142,929
Expenses$1,088,129
Net income$54,800
Net assets$1,399,401

Notable sources of revenue

Percent of total revenue
Contributions$164,402
Program services$954,026
Investment income$22,838
Other (net)$1,663

Assets / debt

Total assets$1,517,881
Total liabilities$118,480
Net assets$1,399,401

Compensation

Officers and key employees$165,850
Share of expenses15.2%
Fiscal year ending December 2022
Revenue$790,764
Expenses$643,368
Net income$147,396
Net assets$1,344,601

Notable sources of revenue

Percent of total revenue
Contributions$167,652
Program services$621,129
Investment income$17
Other (net)$1,966

Assets / debt

Total assets$1,469,916
Total liabilities$125,315
Net assets$1,344,601

Compensation

Officers and key employees$160,000
Share of expenses24.9%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?